Humira, Stelara, Enbrel, Entyvio and Remicade impair immune performance

November 2, 2016

What are the dangers of Humira, Stelara, Enbrel and Entyvio?

You’ve heard the names – names like Humira, Stelara, Enbrel and Entyvio. You are undoubtedly also familiar with the names of the conditions they treat – diseases like rheumatoid arthritis, inflammatory bowel disease, Crohn’s disease, ulcerative colitis and psoriatic arthritis.

Wonder drugs they are and they are effective in treating these conditions previously resistant to modern medicine, but in addition to their outrageous cost, they can set you up for serious life-threatening infections and even some forms of cancer.

Humira, Stelara, Enbrel and Entyvio act as immune system modulators and impair immune response. Translated this means they work by altering your ability to combat infections that you may come in contact with while taking these drugs.

Now I know many patients who suffer from rheumatoid arthritis, Crohn’s disease and ulcerative colitis would say the risks are worth the benefits. And I agree-the symptoms and the effects of these disorders are significant. Nonetheless if you are contemplating utilizing these medications and if you have the conditions like those I’ve described, talk to your physicians and get their recommendation on how you can improve your immune performance during your therapy.

This is Dr. Jim for Be Healthy! Be Happy! and I hope this message has helped you power your path to happiness.